Literature DB >> 2868817

Treatment of urticaria.

E W Monroe.   

Abstract

In conclusion, although the treatment of urticaria, especially chronic urticaria, is often unsatisfactory, considerable progress has been made in this area over the past few years. As we learn more about the pathogenic mechanisms and mediators involved in the production of urticarial lesions, we will be better able to develop more effective treatment modalities. Currently, several medications exist to block the effects of already released histamine on the target organ receptor sites on the cutaneous blood vessels, to prevent the release of histamine from the mast cells, and to interfere with the release or production of other potential mediators of urticaria. Various combinations of these different therapeutic approaches will probably prove most helpful in treating different clinical patterns of urticaria.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2868817

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  3 in total

Review 1.  Anaphylactic shock: mechanisms and treatment.

Authors:  A F Brown
Journal:  J Accid Emerg Med       Date:  1995-06

Review 2.  Histamine2 (H2)-receptor antagonists in the treatment of urticaria.

Authors:  T C Theoharides
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

3.  Alpha-fluoromethylhistidine in the treatment of idiopathic cold urticaria.

Authors:  H Neittaanmäki; J E Fräki; R J Harvima; L Förström
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.